Imported malaria: Key messages in an era of elimination

Tommy Rampling*, Colin J. Sutherland, Christopher J.M. Whitty

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Despite concerted efforts to eliminate malaria, it remains a major global cause of morbidity and mortality with over 200 million annual cases. Significant gains have been made, with the annual global malaria incidence and mortality halving over the past twenty years, using tools such as long-lasting insecticide-treated bed nets and artemisinin-based therapies. Malaria is also a significant cause of life-threatening imported infection in the UK. It is vital for front line clinical staff involved in the assessment of acutely ill patients to be aware of the need for early diagnostic testing, malaria epidemiology, markers of severe infection and developments in antimalarial treatments to optimise patient management. The difference between a good and poor outcome is early diagnosis and treatment. Many of the challenges faced in the quest for global eradication, such as availability of appropriate diagnostic tests, and drug and insecticide resistance could also have future implications for imported malaria.

Original languageEnglish
Pages (from-to)153-156
Number of pages4
JournalClinical Medicine, Journal of the Royal College of Physicians of London
Volume19
Issue number2
DOIs
Publication statusPublished - 2019
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Royal College of Physicians 2019. All rights reserved.

Fingerprint

Dive into the research topics of 'Imported malaria: Key messages in an era of elimination'. Together they form a unique fingerprint.

Cite this